-
World Alzheimer's Day: Fighting "forgotten" with love and understanding
Time of Update: 2020-10-06
Every weekday morning, 81-year-old Aunt Qiang will come to a care center in Shanghai on time to start her new day of life.
-
Dietary strategies based on nia acid may be expected to treat a range of human diseases, including cancer, epilepsy and neurodegenerative diseases.
Time of Update: 2020-10-06
Photo Source: Robin SB Williams, a researcher at CC0 Public Domain, says pyric acid can reverse cellular changes in the body that include a variety of diseases, including cancer, epilepsy and neurodegenerative diseases, and improve the patient's symptoms; the ketogenic diet, a special diet with high fat, low carbohydrates, is widely thought to work by producing chemicals called ketones, which can reduce the body's glucose and insulin signals, thereby protecting the body from cell changes under a variety of diseases.
-
Brain: Scientists have discovered a new type of dementia- LATE disease.
Time of Update: 2020-10-06
UKphoto researchers point out that LATE disease refers to the major age-related TDP-43 encephalopathy (limbic-predominant age-related TDP-43 encephalopathy), which is very similar to the symptoms of Alzheimer's disease, often referred to as dementia, but is induced by different pathogenesis in the brain.
-
J Clin Med: New study helps protect glare.
Time of Update: 2020-10-06
these rich omega-3 fatty acid chemical messengers provide antioxidant defenses and, as a result, are potentially resistant to elevated intra-eye pressure and glare neurodegeneration by eliminating increased systemic oxidative stress.
-
Cell: Scientists develop functional retinas in-body.
Time of Update: 2020-10-06
September 23, 2020 /--- In a recent study, scientists for the first time produced a human-like retinal tissue-like organ model in a culture that could be used to study cell types associated with hereditary eye disease.
-
Alzheimers Res Ther: There are biomarkers in the eye that indicate neurodegeneration.
Time of Update: 2020-10-06
September 23, 2020 /--- A new study led by researchers at Boston Medical Center shows that a biomarker called neurofilament light chain can now be detected in the eye that can be used as a marker for early diagnosis of neurodegenerative diseases.
-
World Alzheimer's Day, September 21 Read the important achievements of Alzheimer's research in recent years!
Time of Update: 2020-10-06
!-- 21 September 2020 is the 27th World Alzheimer's Day, commonly known as Alzheimer's disease. There are about 10 million people with Alzheimer's disease, there is a high prevalence, low awareness, l
-
New discovery! Reproductive cells may like to "eat sweets" and pass this trait on to the body's brain!
Time of Update: 2020-10-06
!--webeditor:page title" -- September 23, 2020 // -- Our work seems to be easier than cells, and when cells work hard to break down some molecules and build others, all we do is feed them, but what ex
-
The pressure is so great that I can't sleep... The consequences may be worse than you might think, new research suggests.
Time of Update: 2020-10-06
they were surprised to find that after stimulating the corresponding neurons in the PVN brain region of mice, there were extensive and significant changes in natural killer cells, B cells, T cells and other immune cells in the blood during insomnia in mice.
-
Too much or too little sleep is harmful to the brain.
Time of Update: 2020-10-06
Dr Sam Gandy, deputy director of the Alzheimer's Research Center at Mount Sinai in New York City, added: "During the circadian rhythm cycle, the lymphatic system of the brain is more active during sleep than at any other time, removing excess toxins, including amyloid beta peptides.
-
Nature Sub-Journal: CRISPR-Cas9, which improves targeted toxic RNA, is expected to treat type I of severe muscular dystrophy.
Time of Update: 2020-10-06
a new study, the researchers confirmed that a dose of RCas9 gene therapy degrades toxic RNA and almost completely reverses the symptoms of the model of mice with strong muscular dystrophy.
-
Stroke: A 42-year follow-up study of twins confirmed that smoking played a causal role in the bleeding of the subcab membrane of the deadly cobwebs.
Time of Update: 2020-10-05
follow-up 869,469 people - during the year, a total of 120 fatal cobweb subcab bleeding events occurred, of which 4 were twins; Over the entire queue, subjects who smoked occasionally or now had an increased risk of dying from subcrystrial bleeding (HR=3.33; 95% CI 2.24-4.95) compared to those who had never smoked or had smoked before.
-
JNNP: Early diagnosis of plasma and cerebrospinal fluid biomarkers in prions and their comparison with survival.
Time of Update: 2020-10-05
results: Age was associated with plasma nerve wire light chain protein (NfL) levels, independent of other blood and CSF biomarkers, in two groups of patients (all RPD cases, r s 0.181, p s 0.006) and in control (r s 0.706, p s 0.003, n s 38).
-
Alzheimer's disease: 9 risk factors, 7 prevention recommendations.
Time of Update: 2020-10-05
1 The incidence and prevalence of Alzheimer's disease in older people almost doubles with age.
2 the occurrence of Alzheimer's disease in people with a family history is genetically related.
-
Neurology: Clinical characteristics of late-oncology alcohol-induced headaches.
Time of Update: 2020-10-05
researchers analyzed the esotypes of headaches, validated the DAIH ICHD esoteric standard, and analyzed whether participants met the criteria for low cerebrospinal fluid (CSF) stress headaches or migraines.
58 percent of patients met the ICHD low cerebrospinal fluid stress headache standard, and 36 percent of the participants met the migraine standard.
-
Nat Commun: Watch out! Even mild brain damage can seriously damage the brain's ability to remove toxins.
Time of Update: 2020-10-05
"Previous lymphatic defects can lead to increased inflammation caused by TBI and decreased cognitive ability," the researchers found that enhancing meninges' lymphatic function after TBI may help reduce nerve inflammation.
-
JNNP: Effects of facial movement in combination with type A botulinum toxin on the health-related quality of life of facial muscle spasms in adults in Thailand: a randomized controlled cross-trial.
Time of Update: 2020-10-05
a small randomized controlled trial (RCT) conducted in a joint study of facial exercises with abnormal facial movements and BTX-A reported no significant reduction in the severity and frequency of facial muscle spasms, but only four HFS patients were included.
-
Nat Commun: e2 APOE has a protective effect on neurodegenerative diseases.
Time of Update: 2020-10-05
APOE genotype associated with the relationship between amyloid and tau neuropathology AD-associated amyloid plaques and Braak graded pathology analyses showed that e2 carriers had a higher and more significant protective effect than e3/e3 and e4 carriers.
-
JNNP: Non-targeted metabolomics studies the pathogenesis of ALS.
Time of Update: 2020-10-05
metabolomic analysis can provide alS with new hypotheses, therapeutic targets, and potential biomarkers.
blood plasma was also provided to control groups with gender and age matching.
-
Nature: Over the course of eight years, Yuan's team has provided a new direction for the treatment of neurodegenerative diseases in humans.
Time of Update: 2020-10-05
The study successfully screened the small molecular compound Apostatin-1, which inhibits both cell death and activates autophagy, and identified its target TRADD protein, further confirming that targeting TRADD is very safe, an eight-year effort that provides a new direction for treating neurodegenerative diseases in humans.
